Article · 31 Mar 2025
Review articlePublished 21 Jan 2017
The Continued Promise of Neuroprotection for Acute Stroke Treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Stroke is the second leading cause of death. However, effective pharmocologic treatment options are still extremely limited and applicable to only a small fraction of patents. The translational failure in finding an effective neuroprotectant for ischemic strokes has generated an active discussion in this field. One focus has been on validating systems for testing neuroprotectants. This review discusses some fundamental issues in experimental stroke that are worthy of further exploration. We begin with a general review of the current status of experimental stroke research and then move on to a discussion of the determining factors and processes that control and differentiate the fate of ischemic ischemic cells and tissue. We propose several strategies of neuroprotection for ischemic strokes with an emphasis on manipulating cellular energy state.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Experimental Stroke & Translational Medicine.
Article · 31 Mar 2025
Preclinical to Clinical Translation: Bridging the Gap in Biomedical Research
Article · 31 Mar 2025
Pharmacogenomics: Personalizing Medicine Through Genetic Insights
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Experimental Stroke & Translational Medicine
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Shimin Liu”
- BylineArticles whose byline prints “Steven R Levine”